Three-parents-baby - A new DNA Technology

  • This is a leap on DNA technology. It’s not cloning but very much close to it. Human cloning is banned throughout the world. But animal and botanical cloning is rapidly in use. Cloned sheep Dolly lived six healthy years. However, the technology of three-parents-baby is not cloning (but the technic is loaned from part of the process of cloning). First a brief description how it is done then enjoy the full article. In the gametes (male and female reproductive cells) the cell has nucleus and semi liquid cytoplasm enclosed by cell wall. The nucleus has a set of DNAs collectively called chromosomes. In the cytoplasm there are other vital bodies including mitochondria. Mitochondria has also another set of DNAs. While the nucleus DNA shed heredity characteristics to newly born baby from male the mitochondrial DNA transfers the mother’s characteristics. This all happens during the process of male and female gametes meiosis and mitosis process and formation of embryo. In the three-parents-technology the female cells are picked up in the lab and its cytoplasm is removed. Then some zygotes of another person’s zygotes are taken and they are deprived of nucleus. In the nucleus deprived gametes the mother’s nucleus is inserted. Then the newly engineered gamete is subjected to in vitro fertilization in a fertility clinic. Now enjoy the article.

    “It’s a boy! A five-month-old boy is the first baby to be born using a new technique that incorporates DNA from three people, New Scientist can reveal. “This is great news and a huge deal,” says Dusko Ilic at King’s College London, who wasn’t involved in the work. “It’s revolutionary.”
    The controversial technique, which allows parents with rare genetic mutations to have healthy babies, has only been legally approved in the UK. But the birth of the child, whose Jordanian parents were treated by a US-based team in Mexico, should fast-forward progress around the world, say embryologists.
    Briefing: Everything you wanted to know about ‘3-parent’ babies

    The boy’s mother carries genes for Leigh syndrome, a fatal disorder that affects the developing nervous system. Genes for the disease reside in DNA in the mitochondria, which provide energy for our cells and carry just 37 genes that are passed down to us from our mothers. This is separate from the majority of our DNA, which is housed in each cell’s nucleus.
    Around a quarter of her mitochondria have the disease-causing mutation. While she is healthy, Leigh syndrome was responsible for the deaths of her first two children. The couple sought out the help of John Zhang and his team at theNew Hope Fertility Center in New York City.

    John Zhang holds the baby
    Zhang has been working on a way to avoid mitochondrial disease using a so-called “three-parent” technique. In theory, there are a few ways of doing this. The method approved in the UK is called pronuclear transfer and involves fertilising both the mother’s egg and a donor egg with the father’s sperm. Before the fertilised eggs start dividing into early-stage embryos, each nucleus is removed. The nucleus from the donor’s fertilised egg is discarded and replaced by that from the mother’s fertilised egg.
    Meet your mitochondria: The powerful aliens that lurk within you

    But this technique wasn’t appropriate for the couple – as Muslims, they were opposed to the destruction of two embryos. So Zhang took a different approach, called spindle nuclear transfer. He removed the nucleus from one of the mother’s eggs and inserted it into a donor egg that had had its own nucleus removed. The resulting egg – with nuclear DNA from the mother and mitochondrial DNA from a donor – was then fertilised with the father’s sperm.
    Gene editing: A guide to the genetic revolution on our doorstep

    Zhang’s team used this approach to create five embryos, only one of which developed normally. This embryo was implanted in the mother and the child was born nine months later. “It’s exciting news,” says Bert Smeets at Maastricht University in the Netherlands. The team will describe the findings at the American Society for Reproductive Medicine’s Scientific Congress in Salt Lake City in October.
    Neither method has been approved in the US, so Zhang went to Mexico instead, where he says “there are no rules”. He is adamant that he made the right choice. “To save lives is the ethical thing to do,” he says.
    The team seems to have taken an ethical approach with their technique, says Sian Harding, who reviewed the ethics of the UK procedure. The team avoided destroying embryos, and used a male embryo, so that the resulting child wouldn’t pass on any inherited mitochondrial DNA. “It’s as good as or better than what we’ll do in the UK,” says Harding.
    A remaining concern is safety. Last time embryologists tried to create a baby using DNA from three people was in the 1990s, when they injected mitochondrial DNA from a donor into another woman’s egg, along with sperm from her partner. Two of the fetuses developed genetic disorders, and the technique was halted by the US Food and Drug Administration. The problem may have arisen from the fetuses having mitochondria from two sources.
    When Zhang and his colleagues tested the boy’s mitochondria, they found that less than 1 per cent carry the mutation. Hopefully, this is too low to cause any problems; generally it is thought to take around 18 per cent of mitochondria to be affected before problems start. “It’s very good,” says Ilic.
    Smeets agrees, but cautions that the team should monitor the child to make sure the levels stay low. There’s a chance that faulty mitochondria could be better at replicating, and gradually increase in number, he says. “We need to wait for more births, and to carefully judge them,” says Smeets.